MedTrace Logo

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

NCT02229344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2025-04-27

No results posted yet for this study

Summary

The purpose of this study is to describe clinical course of newly diagnosed moderate to severe ulcerative colitis (chronic inflammatory disease of the colon) in tertiary referral hospitals in Korea for 5-year follow-up under usual care.

Conditions

  • Colitis, Ulcerative

Interventions

OTHER

No Intervention

Participants with newly diagnosed moderate to severe ulcerative colitis in a tertiary referral hospital within 4 weeks before prior to enrollment will be observed.

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    lead INDUSTRY

Principal Investigators

  • Janssen Korea, Ltd., Korea Clinical Trial · Janssen Korea, Ltd., Korea

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-01
Primary Completion
2022-02-22
Completion
2022-02-22

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229344 on ClinicalTrials.gov